Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
06/14/2018 06/15/2018 06/18/2018 06/19/2018 06/20/2018 Date
67.33(c) 68.68(c) 68.25(c) 67.67(c) 67.96 Last
3 789 473 8 122 718 3 112 171 2 284 864 126 232 Volume
+1.75% +2.01% -0.63% -0.85% +0.43% Change
More quotes
Financials (EUR)
Sales 2018 35 273 M
EBIT 2018 8 334 M
Net income 2018 5 099 M
Debt 2018 15 707 M
Yield 2018 4,46%
Sales 2019 36 525 M
EBIT 2019 8 850 M
Net income 2019 5 530 M
Debt 2019 13 588 M
Yield 2019 4,69%
P/E ratio 2018 16,28
P/E ratio 2019 15,21
EV / Sales2018 2,86x
EV / Sales2019 2,71x
Capitalization 85 245 M
More Financials
Company
Sanofi engages in the research, production and distribution of pharmaceutical products.It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines.The Pharmaceuticals segment comprises the commercial operations of the following global franchises:... 
Sector
Pharmaceuticals
Calendar
06/27Shareholder meeting
More about the company
Surperformance© ratings of Sanofi
Trading Rating : Investor Rating :
More Ratings
Latest news on SANOFI
08:02aLatecomer Sanofi looks to catch next wave of cancer therapies
RE
06/19SANOFI : Recipharm buys Sanofi CMO site in UK, signs long-term supply deal
AQ
06/19EVOTEC : and Sanofi Sign Definitive Agreement to Combat Infectious Diseases
AQ
06/19SANOFI : Evotec says Sanofi deal makes it anti-infectives powerhouse
AQ
06/19PEUGEOT : Sanofi poaches former PSA finance boss Chasseloup de Chatillon
RE
06/19Sanofi Names Jean-Baptiste Chasseloup de Chatillon as CFO, Executive VP
DJ
06/19SANOFI : appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President..
AQ
06/19SANOFI : appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President..
GL
06/19SANOFI : Sanofi completes its acquisition of Ablynx following the expiration of ..
GL
06/18SANOFI : Disclosure of trading in own shares
GL
More news
Sector news : Pharmaceuticals - NEC
08:02aLatecomer Sanofi looks to catch next wave of cancer therapies
RE
07:25aMerck KGaA Partners With Alibaba Health in China
DJ
06/19High Times refreshes IPO plans as cannabis companies build buzz on Wall Stree..
RE
06/19MERCK : to Distribute HistoCyte Laboratories Products
DJ
06/19Alexion Uses FDA Priority-Review Voucher for Blood Disorder
DJ
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on SANOFI 
SANOFI - 05/15
Attractive price levels
BUY
SANOFI - 2017
Good timing to go long again
BUY
More Strategies
Latest Tweets
08:03aLatecomer Sanofi looks to catch next wave of cancer therapies  
06/19They're fans of foreign stocks that have fallen out of favor, such as Sanofi ..
3
06/19Sanofi transfers infectious disease unit to Evotec
1
06/19$ABLX ... KBC Securities Morning Note 19-6-2018 ABLX BB, BANI BB, CYAD:BB, D.. 
06/19Oddo - Oddo convertible news 19/06/2018: Orange: the State’s 23% stake to be .. 
More tweets
Qtime:168
News from SeekingAlpha
06/19Translate Bio Prepares For $100 Million U.S. IPO 
06/19Merger Arbitrage Mondays - June 18, 2018 
06/19Sanofi transfers infectious disease unit to Evotec 
06/19Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice Presiden.. 
06/16STOCKS TO WATCH : Don't Sleep On Vienna 
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 77,0 €
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & Executive VP-Finance
Elias A. Zerhouni President-Global Research & Development
Ameet Nathwani Executive Vice President-Medical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-4.41%98 673
JOHNSON & JOHNSON-12.25%328 858
PFIZER0.39%212 690
NOVARTIS-8.25%193 330
ROCHE HOLDING LTD.-14.81%184 168
MERCK AND COMPANY8.39%166 880